UCSF Diabetes, Brain Tumor Stem Cell Grants To Drive Development Of Therapies
Two teams of UCSF scientists have received grants from the California Institute for Regenerative Medicine to advance their stem cell based strategies for treating diabetes and brain tumors. The intent of the grants is for teams to file new drug applications to the U.S. Food and Drug Administration within four years, driving potential therapies toward clinical trials. The two grants, awarded to collaborative scientific teams, total $39.2 million.
[Read the full article here]Related News:
NHLBI grants US$170 mn for stem cell research
Stem cell researchers bring in $9.8 million in Connecticut grants
Stem cell grants for study of diabetes, brain tumors